There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Transapical aortic valve replacement (TAVR) is increasingly being applied in conventionally
inoperable patients with aortic stenosis. The utility of the cardiac marker NT-pro-BNP
has yet not been assessed in this setting.